Skip to content

LeMaitre Vascular

US · LMAT #2839 by market cap Listed 1970
73.61 -1.25 -1.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 24 in the most recent period (2026/Q3).
  • Total institutional ownership rose 0.9 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
103.32% +0.90pp
Institutions
371 -24
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund92.71%
Individual/Insider6.84%
Hedge Fund3.97%
Public Company3.58%
Government Pension Fund1.41%
Private Company0.67%
Insurance Company0.50%
Family Office/Trust0.24%
Sovereign Wealth Fund0.16%

Top holders as of 2026-09-30

BlackRock 14.62% · 3.35M sh
George LeMaitre 6.40% · 1.46M sh
First Trust Advisors L.P. 4.78% · 1.09M sh
Congress Asset Management Company, LLP 4.20% · 961.51K sh
Vanguard Capital Management, LLC 4.19% · 959.53K sh
Copeland Capital Management, LLC 4.04% · 924.08K sh
State Street Global Advisors 3.97% · 908.36K sh
Conestoga Capital Advisors, LLC 3.84% · 878.58K sh
T. Rowe Price Group, Inc. 3.30% · 755.14K sh
Geode Capital Management, LLC 3.22% · 736.78K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 32 buys · 18 sells

NameRoleStake
George LeMaitre Chairperson & CEO 6.40%
John O'Connor Independent Director 0.27%
Joseph Pellegrino Director 0.07%
David Roberts President 0.03%
John Roush Independent Director 0.03%
Trent Kamke Officer 0.02%
Lawrence Jasinski Independent Director 0.02%
Bridget Ross Former Independent Director 0.01%
Martha Shadan Independent Director 0.01%
Dorian LeBlanc Chief Financial Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-02 George LeMaitre Chairperson & CEO Other Derivative Acquisition +71 --
2026-09-02 David Roberts President Other Derivative Acquisition +24 --
2026-09-02 Lawrence Jasinski Independent Director Other Derivative Acquisition +4 --
2026-09-02 John Roush Independent Director Other Derivative Acquisition +4 --
2026-09-02 John O'Connor Independent Director Other Derivative Acquisition +4 --
2026-09-02 Trent Kamke Officer Other Derivative Acquisition +13 --
2026-09-02 Joseph Pellegrino Director Other Derivative Acquisition +22 --
2026-09-02 Martha Shadan Independent Director Other Derivative Acquisition +4 --
2026-09-02 Dorian LeBlanc Chief Financial Officer Other Derivative Acquisition +6 --
2026-08-31 John Roush Independent Director Derivative Exercise and Retained +3,444 $48.60
2026-07-28 Bridget Ross Former Independent Director Intent to Sell (Form 144) -4,322 $103.94
2026-06-03 George LeMaitre Chairperson & CEO Other Acquisition +11,974 --
2026-06-03 George LeMaitre Chairperson & CEO Other Disposition -11,974 --
2026-06-03 George LeMaitre Chairperson & CEO Other Derivative Acquisition +61 --
2026-06-03 David Roberts President Other Derivative Acquisition +21 --
2026-06-03 Lawrence Jasinski Independent Director Other Derivative Acquisition +4 --
2026-06-03 John Roush Independent Director Other Derivative Acquisition +4 --
2026-06-03 John O'Connor Independent Director Other Derivative Acquisition +4 --
2026-06-03 Trent Kamke Officer Other Derivative Acquisition +11 --
2026-06-03 Joseph Pellegrino Director Other Derivative Acquisition +19 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

LeMaitre Vascular discussion 0 comments

Add a comment